Koyfin Home > Directory > Health Care > Ampio Pharmaceuticals > EBIT

Ampio Pharmaceuticals EBIT Chart (AMPE)

Ampio Pharmaceuticals annual/quarterly EBIT from 2009 to 2018. Earnings before interest and taxes measures the profit a company generates from its operations, making it synonymous with operating profit. By ignoring tax and interest expenses, it focuses solely on a company's ability to generate earnings from operations, ignoring variables such as the tax burden and capital structure.
  • Ampio Pharmaceuticals EBIT for the quarter ending September 09, 2018 was $-2m a -147.66% increase of 3m year over year
  • Ampio Pharmaceuticals EBIT for the last 12 months ending September 09, 2018 was $-13m a -16.59% increase of 2m year over year
  • Ampio Pharmaceuticals Annual EBIT for 2017 was $-16m a -9.75% increase of 2m from 2016
  • Ampio Pharmaceuticals Annual EBIT for 2016 was $-17m a -41.48% increase of 7m from 2015
  • Ampio Pharmaceuticals Annual EBIT for 2015 was $-24m a -30.12% increase of 7m from 2014
Other Income Statement Metrics:
  • Ampio Pharmaceuticals EBITDA for the quarter ending September 09, 2018 was $-2m a -182.51% increase of 3m year over year
  • Ampio Pharmaceuticals Net Income for the quarter ending September 09, 2018 was $6m a 843.40% increase of 49m year over year
  • Ampio Pharmaceuticals Total Revenue for the quarter ending December 12, 2015 was $0m a 95.43% increase of 0m year over year
View Chart On Koyfin

Quarterly AMPE EBIT Data

09/2018$-2m
06/2018$-3m
03/2018$-4m
12/2017$-5m
09/2017$-3m
06/2017$-5m
03/2017$-3m
12/2016$-3m
09/2016$-3m
06/2016$-4m

Annual AMPE EBIT Data

2017$-16m
2016$-17m
2015$-24m
2014$-31m
2013$-24m
2012$-12m
2011$-11m
2010$-7m
2009$-2m